Nectin Therapeutics
PrivateLast Round
VC Round
May 6, 2024
Total Funding Raised
$11.4M
Company Overview
Nectin Therapeutics is a biotechnology company that develops next-generation immuno-oncology therapies and antibody-drug conjugates to treat solid and hematological malignancies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nectin Therapeutics Comparables
Compare Nectin Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GSK plc | 73% | |
| iTeos Therapeutics | 73% | |
| Compugen Ltd. | 71% | |
Nectin Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 6, 2024 | ||||
| VC Round | May 16, 2023 | ||||
| Grant | Nov 30, 2022 | ||||
| VC Round | Mar 7, 2022 | ||||
| Series A | Jul 14, 2020 |
Key People
Founding team and executive leadership
Nectin Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Biotech Fund | VC Round, Grant |
| Peregrine Ventures (California) | Grant |
| The University of Texas MD Anderson Cancer Center | Grant |
| Integra Holdings | Series A, VC Round, Grant |
| aMoon | Grant |
| Cancer Focus Fund | VC Round, Grant |
| Guangzhou Sino-Israel Bio-Industry Investment Fund | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 30, 2022
$5.4M grant round led by Israel Biotech Fund.
Nectin Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nectin Therapeutics's valuation, stock price, and market status.